PropertyValue
?:abstract
  • From the Document: \'This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the ViroKey™ SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] RT-PCR [reverse transcription polymerase chain reaction] Test The ViroKey SARS-CoV-2 RT-PCR Test is authorized for use with certain respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider \'
is ?:annotates of
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Fact Sheet for Healthcare Providers: Vela Operations Singapore Pte Ltd.;ViroKey™ SARS-CoV-2 RT-PCR Test
?:type
?:who_covidence_id
  • #740222
?:year
  • 2020

Metadata

Anon_0  
expand all